You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2025

Precision Dose Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PRECISION DOSE INC

PRECISION DOSE INC has one approved drug.



Summary for Precision Dose Inc
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Precision Dose Inc

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Precision Dose Inc PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 207686-001 Jul 14, 2017 AP RX No No ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 1 of 1 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: Precision Dose Inc – Market Position, Strengths & Strategic Insights

In the ever-evolving pharmaceutical industry, companies must constantly adapt to maintain their competitive edge. Precision Dose Inc., a pioneer in unit dosing, has carved out a unique position in the market. This comprehensive analysis delves into Precision Dose's market position, strengths, and strategic insights, providing valuable information for industry professionals and investors alike.

Company Overview

Precision Dose Inc. is an FDA-registered producer of unit-dose pharmaceutical products[1]. Founded with a focus on innovation and customer satisfaction, the company has established itself as a leader in the precision dosing market. Their product portfolio includes a wide range of oral liquid medications in unit-dose cups and pre-filled oral syringes, as well as tablets in unit-dose blister cards[1].

Market Position

Current Market Standing

Precision Dose operates in the rapidly growing precision dosing market, which was valued at USD 180.22 Million in 2023 and is projected to reach USD 278.63 Million by 2029, growing at a CAGR of 7.61%[2]. The company's focus on unit-dose pharmaceutical products positions it well to capitalize on this growth.

Competitive Advantage

Precision Dose's competitive advantage lies in its specialization in unit dosing. As pioneers in this field, they have developed expertise that sets them apart from competitors. Their products offer several benefits:

  1. Increased accuracy in medication administration
  2. Reduced risk of contamination
  3. Improved patient compliance
  4. Enhanced inventory management for healthcare facilities

Product Portfolio

Pre-filled Unit-Dose Oral Syringes

Precision Dose offers a range of medications in pre-filled unit-dose oral syringes, including:

  • Acetaminophen Oral Suspension
  • Children's Ibuprofen Oral Suspension
  • Morphine Sulfate Oral Solution CII[9]

These products cater to various patient needs, from common pain relief to more specialized treatments.

Pre-filled Unit-Dose Cups

The company also provides medications in pre-filled unit-dose cups, such as:

  • Acetaminophen Oral Suspension
  • Children's Acetaminophen Oral Suspension (Dye-Free)[9]

This format offers convenience for healthcare providers and patients alike.

Unit-Dose Tablets/Capsules

Precision Dose's product line extends to unit-dose tablets and capsules, including:

  • Calcium Acetate Capsules
  • Diphenhydramine HCl Tablets
  • Folic Acid Tablets
  • Oseltamivir Phosphate Capsules[9]

This diverse range of products allows the company to meet various medical needs across different therapeutic areas.

Strengths and Core Competencies

Specialized Expertise

Precision Dose's management team consists of highly specialized professionals with decades of experience in pharmaceutical manufacturing, repackaging, and distribution[1]. This expertise allows the company to maintain high-quality standards and innovate in the unit dosing space.

FDA Registration

As an FDA-registered producer, Precision Dose adheres to strict quality and safety standards[1]. This registration enhances the company's credibility and opens doors to various market opportunities.

Innovation Focus

Precision Dose is committed to innovation, as evidenced by their product development efforts and the introduction of new dosing formats like ENFit syringes[9].

Customer-Centric Approach

The company's commitment to total customer satisfaction[9] suggests a strong focus on meeting client needs and maintaining long-term relationships.

Market Trends and Opportunities

Growing Demand for Precision Medicine

The precision medicine market, which includes precision dosing, is expected to grow from USD 81.08 Billion in 2023 to USD 175.6 Billion by 2030, at a CAGR of 11.5%[4]. This trend presents significant growth opportunities for Precision Dose.

Increasing Focus on Patient Safety

With growing concerns about medication errors, the demand for unit-dose products is likely to increase. Precision Dose's products address this need directly, positioning the company favorably in the market.

Technological Advancements

The integration of artificial intelligence and machine learning in dosing protocols enhances precision and efficiency[2]. Precision Dose could leverage these technologies to further improve its products and services.

Challenges and Potential Threats

Regulatory Compliance

The pharmaceutical industry is heavily regulated, and companies must stay compliant with evolving standards. In April 2024, Precision Dose agreed to pay $75,000 for allegedly violating the Civil Monetary Penalties Law by failing to submit timely pricing data[5]. This incident highlights the importance of maintaining strict regulatory compliance.

Market Competition

As the precision dosing market grows, competition is likely to intensify. Precision Dose will need to continue innovating and differentiating its offerings to maintain its market position.

Pricing Pressures

With increasing focus on healthcare costs, there may be pressure to reduce prices. Precision Dose will need to balance cost-effectiveness with maintaining product quality.

Strategic Insights

Expansion into New Therapeutic Areas

Precision Dose could consider expanding its product portfolio to cover additional therapeutic areas, leveraging its expertise in unit dosing.

Technological Integration

Investing in technologies like artificial intelligence for dose optimization could provide a significant competitive advantage.

Strategic Partnerships

Collaborating with healthcare providers, pharmaceutical companies, or technology firms could open new avenues for growth and innovation.

Global Expansion

While Precision Dose has a strong presence in North America, exploring opportunities in other regions could drive future growth.

Future Outlook

The precision dosing market is poised for significant growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in pharmacogenomics, and growing demand for personalized healthcare solutions[2]. Precision Dose, with its established market position and focus on innovation, is well-positioned to capitalize on these trends.

"The Global Precision Dosing Market refers to the burgeoning industry focused on delivering precise doses of medications and therapies tailored to individual patient needs. This market encompasses a wide range of technologies, including advanced drug delivery systems, personalized medicine platforms, and innovative dosage calculation methods."[2]

As healthcare continues to evolve towards personalized and patient-centric approaches, companies like Precision Dose that specialize in tailored dosing solutions are likely to play an increasingly important role.

Key Takeaways

  1. Precision Dose Inc. is a leader in the unit-dose pharmaceutical product market, with a strong focus on innovation and customer satisfaction.
  2. The precision dosing market is growing rapidly, presenting significant opportunities for Precision Dose to expand its market share.
  3. The company's strengths lie in its specialized expertise, FDA registration, and diverse product portfolio.
  4. Challenges include regulatory compliance, increasing competition, and potential pricing pressures.
  5. Future growth strategies could include expanding into new therapeutic areas, integrating advanced technologies, forming strategic partnerships, and exploring global markets.
  6. The shift towards personalized medicine and increased focus on patient safety aligns well with Precision Dose's core competencies, suggesting a positive outlook for the company.

FAQs

  1. What is Precision Dose Inc.'s main focus? Precision Dose Inc. specializes in producing unit-dose pharmaceutical products, including oral liquid medications in unit-dose cups and pre-filled oral syringes, as well as tablets in unit-dose blister cards.

  2. How large is the precision dosing market? The precision dosing market was valued at USD 180.22 Million in 2023 and is projected to reach USD 278.63 Million by 2029, growing at a CAGR of 7.61%.

  3. What are the key advantages of unit-dose products? Unit-dose products offer increased accuracy in medication administration, reduced risk of contamination, improved patient compliance, and enhanced inventory management for healthcare facilities.

  4. How does Precision Dose ensure product quality? Precision Dose is an FDA-registered producer, which means it adheres to strict quality and safety standards in its manufacturing and packaging processes.

  5. What future trends might impact Precision Dose's business? Key trends include the growing demand for precision medicine, increasing focus on patient safety, and technological advancements in dosing protocols, such as the integration of artificial intelligence and machine learning.

Sources cited: [1] https://rxinsider.com/market-buzz/institution.php?p=576-precisiondose [2] https://www.techsciresearch.com/report/precision-dosing-market/8000.html [4] https://www.strategicmarketresearch.com/market-report/precision-medicine-market [5] https://oig.hhs.gov/fraud/enforcement/precision-dose-agreed-to-pay-75000-for-allegedly-violating-the-civil-monetary-penalties-law-by-failing-to-submit-timely-pricing-data/ [9] https://www.precisiondose.com

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.